The following excerpt is from the company's SEC filing.
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Effective April 29, 2015 Matthew Pfeffer resigned as director of DS Healthcare Group, Inc. (the Company). Mr. Pfeffer has not expressed any disagreement with the Company on any matter relating to the Companys operations, policies or practices. Mr. Pope, a current director of the Company, has been appointed to serve as the Companys Audit Committee chairman following Mr. Pfeffers resignation. Mr. Pope satisfies SEC's requirement of an audit committee financial expert and Nasdaqs financial sophistication requirement.
Effective April 29, 2015, the board of directors of DS Healthcare Group, Inc. (the Company) appointed Michael Pope to fill the recently created vacancy on the Companys board of directors. Mr. Pope shall also serve on the Companys audit, compensation and nominating committees. Mr. Pope, age 34, has served as managing director of Vert Capital Corp., a merchant bank located in California, since October 2011. From August 2009 through December 2012, he served as managing partner of Pope Taylor PLLC, a public accounting and consulting firm. From May 2008 through December 2011, he served as chief financial officer and chief operating officer of Fringe Media, LLC, a skincare and beauty care retailer. Mr. Pope is a graduate of Brigham Young University with a bachelor and masters degree in accounting. Mr. Pope is also a certified public accountant.
The Company has agreed to issue Mr. Pope up to 5,000 shares of restricted common stock for serving on the board of directors. Such shares shall vest in four (4) equal tranches over a period of twelve (12) months from his date of appointment.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DS HEALTHCARE GROUP, INC.
Date: April 30, 2015
/s/ Daniel Khesin
Chief Executive Officer
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever DS HEALTHCARE GROUP, INC. makes a similar move, sign up!